Utilizing the Skin Transcriptome as a Tool for Biomarker Profiling and Measurements of Efficacy
Time: 11:45 am
day: Day One Clinical Track AM
Details:
- Exploring MADAD transcriptome, a gene signature for key pathways of AD to evaluate therapeutic responses
- Showing the clinical efficacy of RAPT193 with improved MADAD transcriptome
- Utilizing the skin transcriptome beyond CCR4 antagonism
